Related Experiment Video
Updated: May 29, 2026
11:19
Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
Published on: February 25, 2011
Antibiotics that target protein synthesis.
Lisa S McCoy1, Yun Xie, Yitzhak Tor
1Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Wiley Interdisciplinary Reviews. RNA
|September 30, 2011
Summary
Bacterial ribosomes are key targets for antibiotics, with drugs binding to specific sites like the A-site, peptidyl transferase center, or peptide exit tunnel. New antibiotic development is crucial due to rising bacterial resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- The bacterial ribosome is essential for protein synthesis and a primary target for antibacterial drugs.
- Many antibiotics function by binding to specific sites on the ribosome, including the 30S A-site, 50S peptidyl transferase center (PTC), and 50S peptide exit tunnel.
- The emergence of antibiotic-resistant bacteria necessitates the development of novel antibacterial agents and therapeutic strategies.
Purpose of the Study:
- To review and classify major antibiotic classes targeting the bacterial ribosome based on their binding sites.
- To highlight the importance of high-resolution structural data in understanding antibiotic mechanisms of action.
- To emphasize the ongoing need for new antibiotics due to increasing bacterial resistance.
Main Methods:
- Literature review and classification of antibiotics based on their ribosomal targets.
- Analysis of structural data for ribosome-bound antibiotics.
- Discussion of antibiotic mechanisms of action at the molecular level.
Main Results:
- Antibiotics target distinct ribosomal sites: A-site (e.g., aminoglycosides), PTC (e.g., oxazolidinones), and peptide exit tunnel (e.g., macrolides).
- Most antibiotics primarily interact with the ribosomal RNA components.
- Recent decades have seen limited introduction of new antibiotic classes, underscoring the resistance challenge.
Conclusions:
- Targeting the bacterial ribosome remains a critical strategy in combating bacterial infections.
- Structural insights into antibiotic-ribosome interactions are vital for designing next-generation antibacterial drugs.
- Continued research is essential to address the threat of antibiotic resistance and discover novel therapeutic agents.
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...